Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone injection versus intra-articular laser therapy for knee osteoarthritis
IRCT20190306042945N8Phase 3Recruiting
- Sponsor
- Iran University of Medical Sciences
- Start
- Sep 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of triamcinolone acetonide in knee osteoarthritis (OA) (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Pain assessed by Visual Analogue Scale at month 1, Function assessed by Persian WOMAC at month 1 and 1 more. Started Sep 2026; status: recruiting.
02
Drugs
triamcinolone acetonide
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20190306042945N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190306042945N8.